Amid the rising novel coronavirus cases in the country, the Indian government said it has started discussions on the availability of Covid-19 vaccine to those who need it.Speaking at the health ministry press conference today, Dr VK Pal, Member (Health), NITI Aayog said, “Discussions have already begun how will the vaccines be made available to all those who need it.”Pal also added that India’s two most important Covid-19 vaccines are now in phase 1 and phase 2 of their trials.
The member of country’s leading think tank also said government will leave no stone unturned to ensure people of India and international community have access to an Indian vaccine as early as possible. Every possible facilitation will be ensured making sure trials conducted scientifically and ethically and we arrive at an affordable option.
Earlier, the Drugs Controller General of India (DCGI) had permitted two vaccines; one developed by the Bharat Biotech International Limited and another one by ZydusCadila Healthcare Ltd to go in for the first and second phase of human clinical trials.
Bharat Biotech’s vaccine candidate Covaxin, which is India’s first indigenous Covid-19 vaccine, has started human trials. In phase I, the vaccine would be tested on 375 volunteers. Covaxin, which has been developed by Bharat Biotech in collaboration with ICMR and NIV, Pune, will be tested on more than 1,100 people in phase 1 and 2 clinical trials.
There are 12 places where the trial for Covaxin will take place as per the Indian Council for Medical Research (ICMR).On Monday, AIIMS-Delhi began recruiting volunteers for conducting human clinical trials Covaxin, said Director Dr Randeep Guleria. The institute is among the 12 sites selected by ICMR for Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.